Gyre Therapeutics (GYRE) Change in Acquisitions & Divestments (2012 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Change in Acquisitions & Divestments of $10.1 million for Q1 2026, down 9.98% year-over-year from $11.2 million in Q1 2025, and up 137.63% quarter-over-quarter from $4.2 million in Q4 2025.
Gyre Therapeutics (GYRE) Change in Acquisitions & Divestments (2012 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Change in Acquisitions & Divestments for 13 consecutive years, with $10.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 9.98% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $14.3 million (up 27.9% YoY), while the FY2025 annual figure was $15.4 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments grew to $10.1 million in Q1 2026 per GYRE's latest filing, from $4.2 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $11.2 million in Q1 2025 and bottomed at $2.5 million in Q1 2022.
- Historically, Change in Acquisitions & Divestments has averaged $7.0 million across 3 years, with a median of $7.2 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments plunged 90.92% — and 2026, when it fell 9.98%.
- Gyre Therapeutics' Change in Acquisitions & Divestments stood at $2.5 million in 2022, then surged by 69.29% to $4.2 million in 2025, then jumped by 137.63% to $10.1 million in 2026.
- Business Quant data shows GYRE's Change in Acquisitions & Divestments at $10.1 million in Q1 2026, $4.2 million in Q4 2025, and $11.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 10.07 Mn |
| Mar 31, 2026 | 10.07 Mn |
| Dec 31, 2025 | 4.24 Mn |
| Dec 31, 2025 | 4.24 Mn |
| Mar 31, 2025 | 11.19 Mn |
| Mar 31, 2025 | 11.19 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Sep 30, 2021 | 7.53 Mn |
| Sep 30, 2021 | 7.53 Mn |
| Jun 30, 2021 | 11.05 Mn |
| Jun 30, 2021 | 11.05 Mn |
| Mar 31, 2021 | 27.58 Mn |
| Mar 31, 2021 | 27.58 Mn |
| Dec 31, 2020 | 33.48 Mn |
| Dec 31, 2020 | 33.48 Mn |